Liquid Biopsy Market by Target Analyte (Circulating Tumor Cells (Ctcs), Circulating Tumor DNA (CtDNA), Exosomes, Nucleosomes, and Other Biomarkers), by Analytical (Molecular, Proteomic, and Histology/Imaging), by Application (Routine Screening, Patient Work-Up, Early-Stage Disease, and Late-Stage/Metastatic Disease), by Cancer Type (Breast Cancer, Prostate Cancer, Colorectal Cancer, Lung Cancer, Brain Cancer, and Others), by Sample (Blood, Urine, and Others), and by End-User (Hospitals, Research Laboratories, Academia, and Research Centers)-Global Industry Analytics COVID-19 Business Impact, and Trends, 2020–2029

                                          
Abstract
                    
The report covers a forecast and an analysis of the liquid biopsy market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints of the liquid biopsy market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the liquid biopsy market on a global level.

In order to give the users of this report a comprehensive view of the liquid biopsy market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.


The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, product, and regional expansion of major participants involved in the market.

The study provides a decisive view of the liquid biopsy market based on target analyte, analytical, application, sample, cancer type, end-user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Some major players in the global liquid biopsy market include Biocept, Cynvenio, NeoGenomics Laboratories, Qiagen, Trovagene, RainDance Technologies, Guardant Health, Exosome Diagnostics, SAGA Diagnostics AB, Circulogene Theranostics, Inivata, Agena Bioscience, Admeria Health Personal Genome Diagnostics, and Adaptive Biotechnologies.

This report segments the global liquid biopsy market into:

Global Liquid Biopsy Market: Target Analyte Analysis

	Circulating Tumor Cells
	Circulating Tumor DNA
	Exosomes
	Nucleosomes
	Other Biomarkers

Global Liquid Biopsy Market: Analytical Analysis

	Molecular
	Proteomic
	Histology/Imaging

Global Liquid Biopsy Market: Application Analysis

	Routine Screening
	Patient Work Up
	Early-Stage Disease
	Late Stage/Metastatic Disease

Global Liquid Biopsy Market: Sample Analysis

	Blood
	Urine
	Others

Global Liquid Biopsy Market: Cancer Type Analysis

	Breast Cancer
	Lung Cancer
	Colorectal Cancer
	Brain Cancer
	Prostate Cancer
	Others

Global Liquid Biopsy Market: End-User Analysis

	Hospitals
	Research Laboratories
	Academia
	Research Centers

Global Liquid Biopsy Market: Regional Analysis

	North America
	
		The U.S.
	
	
	Europe
	
		UK
		France
		Germany
	
	
	Asia Pacific
	
		China
		Japan
		India
	
	
	Latin America
	
		Brazil
	
	
	Middle East and Africa